Biotherapeutic company Grifols developing COVID-19 treatment Date Published: July 10, 2020 An inside look at the making of a new COVID-19 treatment is playing out in Johnston County. The biotherapeutic company…
How North Carolina beat big competition to win a $350 million investment Date Published: June 30, 2020 Called by the code-name “Project 625,” Grifols Therapeutics pitted North Carolina against the Lone Star State as it considered where…
Grifols begins manufacturing potential COVID-19 treatment at Clayton facility Date Published: June 11, 2020 CLAYTON – Grifols, a global biotherapeutics company with major operations in North Carolina, has begun producing the first specific COVID-19…
Grifols to invest $356M for new facility in Clayton, adding hundreds of jobs Date Published: June 9, 2020 CLAYTON — Grifols, a global biotherapeutics company with already more than 2,000 employees in North Carolina, is investing $351.6 million…
Diagnosed with COVID-19 and recovered? Here’s a chance to contribute to pandemic fight Date Published: May 15, 2020 RESEARCH TRIANGLE PARK – If you’ve been diagnosed with the COVID-19 coronavirus and have recovered, you can help researchers find…
Grifols begins accepting plasma from recovered COVID-19 patients Date Published: May 4, 2020 Grifols is now accepting plasma from volunteer donors who have recovered from the COVID-19 virus at its Raleigh area locations.…
Why a JoCo facility could soon be mass producing a COVID-19 treatment Date Published: April 20, 2020 While the world battles the COVID-19 pandemic, a drugmaker with a massive presence in North Carolina is looking for recovered…
Grifols pursues development of coronavirus treatment based on blood plasma Date Published: April 9, 2020 RESEARCH TRIANGLE PARK – Grifols, a global biotherapeutics company with more than 2,000 employees in North Carolina, will produce and…
Grifols Clayton Plant Working On Coronavirus Vaccine Date Published: March 25, 2020 Grifols volunteers to engage in a public-private sector partnership in an effort to develop a vaccine for COVID-19 Read more…